FasL shedding is reduced by hypothermia in experimental stroke

Journal of Neurochemistry

Volumn 106, Issue 2, 2008, Pages 541-550

  Liu, Liping ^a,b,c,d   Kim, Jong Youl ^c   Koike, Maya A ^a   Yoon, Yone Jung ^c   Tang, Xian Nan ^a   Hualong, Ma ^a   Lee, Hokyou ^a   K Steinberg, Gary ^b   Lee, Jong Eun ^c   Yenari, Midori A ^a,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cerebral ischemia; Fas fasl; Hypothermia; Matrix metalloproteinases; Stroke

Indexed keywords

CASPASE 8; FAS ANTIGEN; FAS LIGAND; GLUCOSE; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; OXYGEN; TNFRSF6 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MODEL; EMBRYO; ENZYME ACTIVATION; FEMALE; FRACTIONATION; HYPOTHERMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; ANALYSIS OF VARIANCE; ANIMAL; ANOXIA; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CRYOANESTHESIA; CYTOLOGY; DRUG EFFECT; EMBRYO (ANATOMY); GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; METABOLISM; METHODOLOGY; MOUSE; NERVE CELL; PHYSIOLOGY; TIME;

RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; ANTIGENS, CD95; CASPASE 8; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GLUCOSE; HYPOTHERMIA, INDUCED; ISCHEMIA; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 51649094117     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05411.x     Document Type: Article

References (42)

1. Bernard S. A., Gray T. W., Buist M. D., Jones B. M., Silvester W., Gutteridge G. and Smith K. (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 346, 557-563.
2. Blankenberg F. G., Kalinyak J., Liu L., Koike M., Cheng D., Goris M. L., Green A., Vanderheyden J. L., Tong D. C. and Yenari M. A. (2006) 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. Eur J Nucl Med Mol Imaging 33, 566-574.
3. Bright R., Raval A. P., Dembner J. M., Perez-Pinzon M. A., Steinberg G. K., Yenari M. A. and Mochly-Rosen D. (2004) Protein kinase C delta mediates cerebral reperfusion injury in vivo. J. Neurosci. 24, 6880-6888.
4. Chan H., Bartos D. P. and Owen-Schaub L. B. (1999) Activation- dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell. Biol. 19, 2098-2108.
5. Cunningham L. A., Wetzel M. and Rosenberg G. A. (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329-339.
6. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S. and Antel J. P. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370.
7. Fu T., Blei A. T., Takamura N., Lin T., Guo D., Li H., O'Gorman M. R. and Soriano H. E. (2004) Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture. Cell Transplant. 13, 667-676.
8. Gill R., Soriano M., Blomgren K. et al. (2002) Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J. Cereb. Blood Flow Metab. 22, 420-430.
9. Hamann G. F., Burggraf D., Martens H. K., Liebetrau M., Jager G., Wunderlich N., DeGeorgia M. and Krieger D. W. (2004) Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke 35, 764-769.
10. Han H. S., Karabiyikoglu M., Kelly S., Sobel R. A. and Yenari M. A. (2003) Mild hypothermia inhibits nuclear factor-kappaB translo- cation in experimental stroke. J. Cereb. Blood Flow Metab. 23, 589-598.
11. Hypothermia after Cardiac Arrest Study Group. (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 346, 549-556.
12. Inamasu J., Suga S., Sato S., Horiguchi T., Akaji K., Mayanagi K. and Kawase T. (2000) Postischemic hypothermia attenuates apoptotic cell death in transient focal ischemia in rats. Acta Neurochir. Suppl. 76, 525-527.
13. Knox P. G., Milner A. E., Green N. K., Eliopoulos A. G. and Young L. S. (2003) Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J. Immunol. 170, 677-685.
14. Krieger D. W. and Yenari M. A. (2004) Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke 35, 1482-1489.
15. Lee J. E., Yoon Y. J., Moseley M. E. and Yenari M. A. (2005) Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J. Neurosurg. 103, 289-297.
16. Liu L. and Yenari M. A. (2007) Therapeutic hypothermia: neuropro- tective mechanisms. Front Biosci. 12, 816-825.
17. Maier C. M., Ahern K., Cheng M. L., Lee J. E., Yenari M. A. and Steinberg G. K. (1998) Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke 29, 2171-2180.
18. Maier C. M., Sun G. H., Kunis D., Yenari M. A. and Steinberg G. K. (2001) Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: neurological outcome and infarct size. J. Neurosurg. 94, 90-96.
19. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T. and Debatin K. M. (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis- inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817.
20. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J. and Krammer P. H. (2001) Therapeutic neutralization of CD95- ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8, 679-686.
21. Matsuno H., Yudoh K., Watanabe Y., Nakazawa F., Aono H. and Kimura T. (2001) Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J. Rheumatol. 28, 22-28.
22. Mitsiades N., Yu W. H., Poulaki V., Tsokos M. and Stamenkovic I. (2001) Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 61, 577-581.
23. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R. J., Shirasaki Y. and Greenberg M. E. (2001) Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21, 7551-7560.
24. Nagata S. and Golstein P. (1995) The Fas death factor. Science 267, 1449-1456.
25. Padosch S. A., Popp E., Vogel P. and Bottiger B. W. (2003) Altered protein expression levels of Fas/CD95 and Fas ligand in differentially vulnerable brain areas in rats after global cerebral ischemia. Neurosci. Lett. 338, 247-251.
26. Phanithi P. B., Yoshida Y., Santana A., Su M., Kawamura S. and Yasui N. (2000) Mild hypothermia mitigates post-ischemic neuronal death following focal cerebral ischemia in rat brain: immunohis- tochemical study of Fas, caspase-3 and TUNEL. Neuropathology 20, 273-282.
27. Powell W. C., Fingleton B., Wilson C. L., Boothby M. and Matrisian L. M. (1999) The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9, 1441-1447.
28. Prakasa Babu P., Yoshida Y., Su M., Segura M., Kawamura S. and Yasui N. (2000) Immunohistochemical expression of Bcl-2, Bax and cytochrome c following focal cerebral ischemia and effect of hypothermia in rat. Neurosci. Lett. 291, 196-200.
29. Qiu J., Whalen M. J., Lowenstein P., Fiskum G., Fahy B., Darwish R., Aarabi B., Yuan J. and Moskowitz M. A. (2002) Upregu- lation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci. 22, 3504-3511.
30. Rosenbaum D. M., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H. and Kessler J. A. (2000) Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J. Neurosci. Res. 61, 686-692.
31. Sakurai T., Itoh K., Liu Y., Higashitsuji H., Sumitomo Y., Sakamaki K. and Fujita J. (2005) Low temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro. Exp. Cell Res. 309, 264-272.
32. Wagner S., Nagel S., Kluge B., Schwab S., Heiland S., Koziol J., Gardner H. and Hacke W. (2003) Topographically graded postis- chemic presence of metalloproteinases is inhibited by hypothermia. Brain Res. 984, 63-75.
33. Wallace J. A., Alexander S., Estrada E. Y., Hines C., Cunningham L. A. and Rosenberg G. A. (2002) Tissue inhibitor of metalloproteinase- 3 is associated with neuronal death in reperfusion injury. J. Cereb. Blood Flow Metab. 22, 1303-1310.
34. Wetzel M., Rosenberg G. A. and Cunningham L. A. (2003) Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur. J. Neurosci. 18, 1050-1060.
35. Wetzel M., Li L., Harms K. M., Roitbak T., Ventura P. B., Rosenberg G. A., Khokha R. and Cunningham L. A. (2008) Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia. Cell Death Differ. 15, 143-151.
36. Xu L., Yenari M. A., Steinberg G. K. and Giffard R. G. (2002) Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J. Cereb. Blood Flow Metab. 22, 21-28.
37. Yenari M. A. and Han H. S. (2006) Influence of hypothermia on post- ischemic inflammation: role of nuclear factor kappa B (NFkap- paB). Neurochem. Int. 49, 164-169.
38. Yenari M. A., Onley D., Hedehus M., deCrespigny A., Sun G. H., Moseley M. E. and Steinberg G. K. (2000) Diffusion- and perfu- sion-weighted magnetic resonance imaging of focal cerebral ischemia and cortical spreading depression under conditions of mild hypothermia. Brain Res. 885, 208-219.
39. Yenari M. A., Iwayama S., Cheng D., Sun G. H., Fujimura M., Morita-Fujimura Y., Chan P. H. and Steinberg G. K. (2002) Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J. Cereb. Blood Flow Metab. 22, 29-38.
40. Yenari M., Wijman C. and Steinberg G. (2004) Effects of hypothermia on cerebral metabolism, blood flow and autoregulation, in Therapeutic Hypothermia (Mayer S. and Sessler D., eds.), pp. 141-178.
41. Marcel Dekker, Inc., New York. Zhang Z., Sobel R. A., Cheng D., Steinberg G. K. and Yenari M. A. (2001) Mild hypothermia increases Bcl-2 protein expression following global cerebral ischemia. Brain Res. Mol. Brain Res. 95, 75-85.
42. Zhao H., Yenari M. A., Cheng D., Sapolsky R. M. and Steinberg G. K. (2005) Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J. Cereb. Blood Flow Metab. 25, 1119-1129.